Olivia Zeiden

Mission: Cure Announces Partnership With Cibus Therapeutics and Greenstone Biosciences to Advance a New Anti-Inflammatory Treatment for Chronic Pancreatitis

News /

December 2025 — Mission: Cure is pleased to announce a collaboration with Cibus Therapeutics and Greenstone Biosciences, two biotechnology companies working together developing next-generation treatments for pancreatic and gastrointestinal diseases. This partnership reflects Mission: Cure’s commitment to keeping the patient community informed about emerging science and supporting efforts to advance new therapies for chronic pancreatitis. […]

Mission: Cure Announces Partnership With Cibus Therapeutics and Greenstone Biosciences to Advance a New Anti-Inflammatory Treatment for Chronic Pancreatitis Read More »

A Community for People Navigating High Triglycerides

News, Patient Resources /

High triglyceride levels can affect people in different ways. High triglycerides often don’t cause symptoms, so many people don’t realize their levels are elevated until a blood test. When triglycerides get extremely high, they can sometimes cause physical signs (like small yellow skin bumps) and can raise the risk of serious complications, including acute pancreatitis

A Community for People Navigating High Triglycerides Read More »

FDA Approves New Treatment for Familial Chylomicronemia Syndrome (FCS)

News, Patient Resources /

We have some exciting news for people living with pancreatitis caused by the FCS genetic mutation. The FDA has approved REDEMPLO® (plozasiran), a new treatment from Arrowhead Pharmaceuticals that lowers triglycerides and reduces acute pancreatitis attacks in adults with Familial Chylomicronemia Syndrome (FCS). This is an important step for people with FCS and a meaningful

FDA Approves New Treatment for Familial Chylomicronemia Syndrome (FCS) Read More »

New Resource: Managing Life with FCS – A Peer Support Toolbox

News, Patient Resources /

High triglycerides are one of the leading causes of pancreatitis, and for some people, extremely high levels can be caused by a rare genetic condition called Familial Chylomicronemia Syndrome (FCS). We’re excited to share a new resource created for and by the FCS community in partnership with Arrowhead Pharmaceuticals. This was specifically designed for people

New Resource: Managing Life with FCS – A Peer Support Toolbox Read More »

The Risks of Steroid Use for Type 1 Autoimmune Pancreatitis (IgG4-RD)

News, Patient Resources /

For people living with IgG4-Related Disease (IgG4-RD), treatment can be complicated. The disease is rare, often misdiagnosed, and can affect many different organs. When it affects the pancreas, it is called Type 1 Autoimmune Pancreatitis (AIP). Steroids are usually the first treatment doctors prescribe because they quickly reduce inflammation, improve symptoms, and induce remission, and

The Risks of Steroid Use for Type 1 Autoimmune Pancreatitis (IgG4-RD) Read More »

Donate Today
Donate Today

Start typing and press enter to search

Scroll to Top

Before You Go

Get Updates in Your Inbox

Stay up-to-date on the latest Mission: Cure news and developments in pancreatitis care.







I am a...: